Clinical and Biologic Significance of MYC Genetic Mutations in De Novo Diffuse Large B-cell Lymphoma - Xu-Monette, Zijun Y.; Deng, Qipan; Manyam, Ganiraju C.; Tzankov, Alexander; Li, Ling; Xia, Yi; Wang, Xiao-xiao; Zou, Dehui; Visco, Carlo; Dybkær, Karen; Li, Jun; Zhang, Li; et al. (Clinical cancer research, 2016)
Keywords: Antibodies, Monoclonal, Murine-Derived - therapeutic use; Antineoplastic Combined Chemotherapy Protocols - therapeutic use; Cohort Studies; Cyclophosphamide - therapeutic use; Doxorubicin - therapeutic use; Female; Humans; Lymphoma, Large B-Cell, Diffuse - drug therapy; Lymphoma, Large B-Cell, Diffuse - genetics; Male; Middle Aged; Mutation - drug effects; Mutation - genetics; Prednisone - therapeutic use; Proto-Oncogene Proteins c-myc - genetics; Translocation, Genetic - drug effects; Translocation, Genetic - genetics; Tumor Suppressor Protein p53 - genetics; Vincristine - therapeutic use